BG104754A - Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists - Google Patents
Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonistsInfo
- Publication number
- BG104754A BG104754A BG104754A BG10475400A BG104754A BG 104754 A BG104754 A BG 104754A BG 104754 A BG104754 A BG 104754A BG 10475400 A BG10475400 A BG 10475400A BG 104754 A BG104754 A BG 104754A
- Authority
- BG
- Bulgaria
- Prior art keywords
- etb
- producing
- carboxylic acid
- acid derivatives
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The compounds are suitable for the treatment of diseases related to the endothelial level. They are derivatives of the carbonic acid with the formula wherein R1-R6, Q, W, X, Y and Z have the meanings given in the description. The invention also relates to a method for their production. 9 claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19809144A DE19809144A1 (en) | 1998-03-04 | 1998-03-04 | New asymmetrically substituted carboxylic acid derivatives, their preparation and use as mixed ET¶LAMBDA¶ / ET¶B¶ receptor antagonists |
PCT/EP1999/001208 WO1999044998A1 (en) | 1998-03-04 | 1999-02-25 | Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104754A true BG104754A (en) | 2001-05-31 |
Family
ID=7859627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104754A BG104754A (en) | 1998-03-04 | 2000-09-07 | Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1060167A1 (en) |
JP (1) | JP2002505324A (en) |
KR (1) | KR20010041537A (en) |
CN (1) | CN1292782A (en) |
AR (1) | AR020317A1 (en) |
AU (1) | AU2624799A (en) |
BG (1) | BG104754A (en) |
BR (1) | BR9908401A (en) |
CA (1) | CA2322541A1 (en) |
CO (1) | CO5080805A1 (en) |
DE (1) | DE19809144A1 (en) |
HR (1) | HRP20000650A2 (en) |
HU (1) | HUP0101173A3 (en) |
ID (1) | ID26183A (en) |
IL (1) | IL137537A0 (en) |
NO (1) | NO20004351L (en) |
PL (1) | PL342806A1 (en) |
SK (1) | SK11752000A3 (en) |
TR (1) | TR200002545T2 (en) |
TW (1) | TW509676B (en) |
WO (1) | WO1999044998A1 (en) |
ZA (1) | ZA991738B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19924892A1 (en) * | 1999-06-01 | 2000-12-07 | Basf Ag | New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists |
JP2003511356A (en) * | 1999-10-06 | 2003-03-25 | ビーエーエスエフ アクチェンゲゼルシャフト | Modulators of cytokine-mediated signaling pathways and integrin αvβ3 receptor antagonists for combination therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4411225A1 (en) * | 1994-03-31 | 1995-10-05 | Basf Ag | Use of carboxylic acid derivatives as a drug |
DE19636046A1 (en) * | 1996-09-05 | 1998-03-12 | Basf Ag | New carboxylic acid derivatives, their production and use as mixed ET¶A¶ / ET¶B¶ receptor antagonists |
-
1998
- 1998-03-04 DE DE19809144A patent/DE19809144A1/en not_active Withdrawn
-
1999
- 1999-02-25 SK SK1175-2000A patent/SK11752000A3/en unknown
- 1999-02-25 JP JP2000534541A patent/JP2002505324A/en active Pending
- 1999-02-25 PL PL99342806A patent/PL342806A1/en unknown
- 1999-02-25 ID IDW20001703A patent/ID26183A/en unknown
- 1999-02-25 AU AU26247/99A patent/AU2624799A/en not_active Abandoned
- 1999-02-25 BR BR9908401-5A patent/BR9908401A/en not_active IP Right Cessation
- 1999-02-25 WO PCT/EP1999/001208 patent/WO1999044998A1/en not_active Application Discontinuation
- 1999-02-25 EP EP99906251A patent/EP1060167A1/en not_active Withdrawn
- 1999-02-25 KR KR1020007009714A patent/KR20010041537A/en not_active Application Discontinuation
- 1999-02-25 IL IL13753799A patent/IL137537A0/en unknown
- 1999-02-25 CN CN998036315A patent/CN1292782A/en active Pending
- 1999-02-25 TR TR2000/02545T patent/TR200002545T2/en unknown
- 1999-02-25 HU HU0101173A patent/HUP0101173A3/en unknown
- 1999-02-25 CA CA002322541A patent/CA2322541A1/en not_active Abandoned
- 1999-03-04 ZA ZA9901738A patent/ZA991738B/en unknown
- 1999-03-04 CO CO99013467A patent/CO5080805A1/en unknown
- 1999-03-04 AR ARP990100920A patent/AR020317A1/en not_active Application Discontinuation
- 1999-03-04 TW TW088103317A patent/TW509676B/en active
-
2000
- 2000-09-01 NO NO20004351A patent/NO20004351L/en not_active Application Discontinuation
- 2000-09-07 BG BG104754A patent/BG104754A/en unknown
- 2000-10-03 HR HR20000650A patent/HRP20000650A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1292782A (en) | 2001-04-25 |
BR9908401A (en) | 2000-10-31 |
HUP0101173A2 (en) | 2002-03-28 |
DE19809144A1 (en) | 1999-09-09 |
WO1999044998A1 (en) | 1999-09-10 |
ZA991738B (en) | 2000-10-11 |
TW509676B (en) | 2002-11-11 |
JP2002505324A (en) | 2002-02-19 |
HRP20000650A2 (en) | 2001-06-30 |
NO20004351D0 (en) | 2000-09-01 |
PL342806A1 (en) | 2001-07-02 |
EP1060167A1 (en) | 2000-12-20 |
ID26183A (en) | 2000-12-07 |
TR200002545T2 (en) | 2000-11-21 |
HUP0101173A3 (en) | 2002-05-28 |
SK11752000A3 (en) | 2001-05-10 |
NO20004351L (en) | 2000-09-01 |
CA2322541A1 (en) | 1999-09-10 |
AR020317A1 (en) | 2002-05-08 |
KR20010041537A (en) | 2001-05-25 |
CO5080805A1 (en) | 2001-09-25 |
IL137537A0 (en) | 2001-07-24 |
AU2624799A (en) | 1999-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN04199A1 (en) | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use | |
BG105177A (en) | Novel substituted pyrazole derivatives | |
HK1089444A1 (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
WO2005061443A3 (en) | Benzoyl-substituted phenylalanine amides | |
RS20050173A (en) | Novel carboxamide compounds having an mch-antagonistic effect,medicaments containing said compounds,and methods for the production thereof | |
BG105650A (en) | Azepinoindole derivatives, the production and use thereof | |
RS20050311A (en) | Selected cgrp antagonists,method for production and use thereof as medicament | |
MY134582A (en) | New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments | |
YU30902A (en) | Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof | |
DE50111753D1 (en) | EPOTHILON SYNTHETIC COMPONENTS I: UNSYMMETRICALLY SUBSTITUTED ACYLOINS AND ACYLOOD DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE FOR THE PREPARATION OF EPOTHILONES AND EPOTHILONE DERIVATIVES | |
CA2333008A1 (en) | New heterocyclically substituted amides, their production and their use | |
UA49884C2 (en) | a-hydro-carboxylic acid derivatives and their use as medicaments | |
ATE426389T1 (en) | METHOD FOR THE PRODUCTION AND USE OF THEAFLAVIN, THEAFLAVIN-3-GALLATE, THEAFLAVIN-3'-GALLATE AND THEAFLAVIN 3,3'-DIGALLATE AND MIXTURES THEIR | |
MY131693A (en) | Arylacetic acid derivatives | |
RS19504A (en) | Novel compounds and compositions as cathepsin inhibitors | |
IL165558A0 (en) | N-benzoylureidocinnamate derivatives method for production and use thereof | |
PL336640A1 (en) | Substituted 3,3-diamino-2- propenonitriles, their production and application | |
BG104754A (en) | Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed eta/etb-receptor antagonists | |
MXPA04005988A (en) | 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives. | |
BG104022A (en) | New beta-amino and beta-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists | |
MXPA05008440A (en) | Method for the production of bicyclic aromatic amino acids and intermediate products thereof. | |
BG105326A (en) | Novel benzoylguanadine derivatives with advantageous properties, method for producing them and their use in the production of medicaments | |
WO2000073274A3 (en) | Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors | |
MXPA04004980A (en) | Ccr-3 receptor antagonists vii. | |
BG105247A (en) | N-substituted azabicycloheptane derivatives, production and use thereof |